Efficacy Of Oral Dexamethasone Versus Parenteral Dexamethasone In The Management Of Mild To Moderate Croup

Launched by AROOJ KHAN · Apr 28, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of two forms of the same medication, dexamethasone, in treating mild to moderate croup in children. Croup is a common illness in young kids that causes a barking cough and can make it hard for them to breathe. The trial will compare oral dexamethasone, which is taken by mouth, to parenteral dexamethasone, which is given as an injection, to see which works better in managing symptoms for children with this condition.

Children between the ages of 2 and 12 who have been diagnosed with croup may be eligible to participate in the study. However, some children cannot participate if they have certain health issues, such as chronic lung diseases or allergies to corticosteroids. If your child joins the study, they will receive one of the two forms of dexamethasone and will be monitored for their symptoms. The goal of this trial is to gather more information about treating mild croup to help doctors provide better advice and care for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient age 2 to 12 years
• • Both genders
• • Diagnosed with croup as operational definitions
• Exclusion Criteria:
• • Patients with chronic pulmonary disease like tuberculosis,
• • Allergy or contraindication of corticosteroid (history of tuberous sclerosis, history of varicella infection during the past three weeks), to corticosteroids,
• • history of corticosteroid administration during the last four weeks,
• • foreign body
• • patients with immunodeficiency disorder